The long-term goal of these studies is to understand mechanisms controlling neural apoptosis, with the expectation that this information will improve therapeutic approaches to decrease neural death following trauma, pathophysiological insults and neurodegenerative disease. The immediate goal of the study is to identify key issues concerning regulation and function of cytoplasmic execution with particular emphasis on biochemical and functional characterization of MRLC-P/membrane blebbing. Several hypotheses will be tested: (1) Apoptotic membrane blebbing is regulated by phosphorylation of MRLC (MRLC-P) through signaling pathways activating myosin light chain kinase and Rho kinase.
Aim 1 proposes to characterize signaling pathways controlling membrane blebbing/MRLC-P during the execution phase. A cell free system has been developed in which cellular extracts from apoptotic and control cells can be treated with various pharmacological inhibitors or co-factors, or be immunodepleted of regulators. (2) MRLC-P/membrane blebbing functions to package the cell and prepare the corpse for phagocytosis by helping to generate apoptotic bodies.
Aim 2 proposes to investigate the role of membrane blebbing/MRLC-P in cellular packaging, formation of apoptotic bodies and phagocytosis. A combination of pharmacological and molecular manipulation will be used to modulate membrane blebbing/MRLC-P and the effects on cellular packaging, formation of apoptotic bodies and phagocytosis noted. (3) Disassembly of microtubules at the onset of execution acts as an initiating event to regulate other downstream events in the execution phase.
Aim 3 proposes to investigate the regulatory role of microtubule disassembly occurring at the onset of execution in subsequent events in execution and determine if extracts from apoptotic cells increase microtubule assembly. The effects of either stabilizing or dissembling microtubules on downstream apoptotic events will be assessed. (4) The Rho family of small GTPases are key regulators of many of the cytoplasmic events occurring in the execution phase.
Aim I V proposes to characterize the role of the Rho family of GTPases (Rok Rac, and Cdc42) in events occurring in the execution phase. Dominant-negative and constitutively-active forms of Rho, Rac, Cdc42, Pak and Rok will be introduced into cells and the effects on the events in cytoplasmic execution noted.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS032465-08
Application #
6625575
Study Section
Special Emphasis Panel (ZRG1-MDCN-2 (01))
Program Officer
Nunn, Michael
Project Start
1994-01-01
Project End
2004-11-30
Budget Start
2002-12-01
Budget End
2003-11-30
Support Year
8
Fiscal Year
2003
Total Cost
$273,922
Indirect Cost
Name
University of Pennsylvania
Department
Pharmacology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Orlando, Kelly A; Stone, Nicole L; Pittman, Randall N (2006) Rho kinase regulates fragmentation and phagocytosis of apoptotic cells. Exp Cell Res 312:5-15
Orlando, Kelly A; Pittman, Randall N (2006) Rho kinase regulates phagocytosis, surface expression of GlcNAc, and Golgi fragmentation of apoptotic PC12 cells. Exp Cell Res 312:3298-311
Raghupathi, Ramesh; Muir, Judith K; Fulp, Carl T et al. (2003) Acute activation of mitogen-activated protein kinases following traumatic brain injury in the rat: implications for posttraumatic cell death. Exp Neurol 183:438-48
Tang, Y; Zhou, H; Chen, A et al. (2000) The Akt proto-oncogene links Ras to Pak and cell survival signals. J Biol Chem 275:9106-9
Zhou, H; Li, X M; Meinkoth, J et al. (2000) Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biol 151:483-94
Erhardt, J A; Hynicka, W; DiBenedetto, A et al. (1998) A novel F box protein, NFB42, is highly enriched in neurons and induces growth arrest. J Biol Chem 273:35222-7
Mills, J C; Stone, N L; Erhardt, J et al. (1998) Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation. J Cell Biol 140:627-36
Mills, J C; Lee, V M; Pittman, R N (1998) Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis. J Cell Sci 111 ( Pt 5):625-36
Erhardt, J A; Pittman, R N (1998) Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment. J Biol Chem 273:23517-23
Zhou, H; Summers, S A; Birnbaum, M J et al. (1998) Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem 273:16568-75

Showing the most recent 10 out of 13 publications